Übersicht Gesetze und Rechtstexte US - USC Title 21: Food and Drugs

US - USC Title 21: Food and Drugs

Neueste gefundene Änderungen

§ 2404 - Coordination and sharing of information with USADA 21 USC 2404	11.08.2026
§ 2403 - Criminal penalties and statute of limitations 21 USC 2403	11.08.2026
§ 2401 - Definitions 21 USC 2401	11.08.2026
§ 2402 - Major international doping fraud conspiracies 21 USC 2402	11.08.2026
§ 2371 - Exception relating to importation of goods 21 USC 2371	11.08.2026
§ 2361 - Treatment of transnational criminal organizations in suspicious transactions reports of the Financial Crimes Enforcement Network 21 USC 2361	11.08.2026
§ 2355 - Treatment of forfeited property of transnational criminal organizations 21 USC 2355	11.08.2026

Alle Rechtstexte

§ 360aaa to 360aaa–6 - Omitted 21 USC 360aaa to 360aaa–6 30.09.2006
§ 360aa - Recommendations for investigations of drugs for rare diseases or conditions 21 USC 360aa 21.11.1997
§ 360a - Clinical trial guidance for antibiotic drugs 21 USC 360a 27.09.2007
§ 360b–1 - Priority zoonotic animal drugs 21 USC 360b–1 27.03.2020
§ 360bbb–0a - Investigational drugs for use by eligible patients 21 USC 360bbb–0a 30.05.2018
§ 360bbb–0 - Expanded access policy required for investigational drugs 21 USC 360bbb–0 18.08.2017
§ 360bbb–1 - Dispute resolution 21 USC 360bbb–1 21.11.1997
§ 360bbb–2 - Classification of products 21 USC 360bbb–2 21.11.1997
§ 360bbb–3a - Emergency use of medical products 21 USC 360bbb–3a 24.06.2019
§ 360bbb–3 - Authorization for medical products for use in emergencies 21 USC 360bbb–3 29.12.2022
§ 360bbb–3b - Products held for emergency use 21 USC 360bbb–3b 24.06.2019
§ 360bbb–3c - Expedited development and review of medical products for emergency uses 21 USC 360bbb–3c 12.12.2017
§ 360bbb–4a - Priority review to encourage treatments for agents that present national security threats 21 USC 360bbb–4a 23.04.2021
§ 360bbb–4b - Medical countermeasure master files 21 USC 360bbb–4b 24.06.2019
§ 360bbb–4 - Countermeasure development, review, and technical assistance 21 USC 360bbb–4 29.12.2022
§ 360bbb–5a - Emerging technology program 21 USC 360bbb–5a 29.12.2022
§ 360bbb–5 - Critical Path Public-Private Partnerships 21 USC 360bbb–5 29.12.2022
§ 360bbb–6 - Risk communication 21 USC 360bbb–6 27.12.2022
§ 360bbb–7 - Notification 21 USC 360bbb–7 09.07.2012
§ 360bbb–8a - Optimizing global clinical trials 21 USC 360bbb–8a 13.12.2016

Feedback